How much funding has Objective Biotechnology raised?

Objective Biotechnology has disclosed $715K raised across 1 round.

Where is Objective Biotechnology headquartered?

Objective Biotechnology is headquartered in Minneapolis, US.

Objective Biotechnology

Minneapolis, US · Founded 2023 · Delaware corporation

Find your way into Objective Biotechnology

Paths you didn't know you had: your email and LinkedIn already hold routes to the Objective Biotechnology team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Objective Biotechnology develops neurotechnology tools for cortex-wide optical access and neural recordings in unrestrained rodent models, along with automated microinjection systems for large-scale genetic manipulation and embryo microinjection. Its products serve researchers working with biological systems.

Biotech Deep Tech Hardware

Founders & leadership

James Grabau Chief Executive OfficerCEO of Objective Biotechnology. James Grabau brings over 25 years of experience in sales, management, and business development from roles at biotech companies.

Daniel SurinachNamed on SEC filing

Amey JoshiNamed on SEC filing

Suhasa KodandaramaiahCTO

Andrew AlegriaNamed on SEC filing

Daryl GohlCSO

Reported raises · per SEC filings

Form D private placements

$715K disclosed across 1 round · 2024

▶$715KraisedNov 2024 · 11 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

James GrabauExecutive Officer
Daniel SurinachExecutive Officer, Director
Amey JoshiExecutive Officer, Director
Suhasa KodandaramaiahExecutive Officer, Director
Andrew AlegriaExecutive Officer, Director
Daryl GohlExecutive Officer, Director

Offering amount: $1M
Amount sold: $715K
First sale: Nov 2024
Incorporated: Corporation, Delaware, 2023
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

InvenInven provides AI-powered workflows for investment and consulting firms to automatically generate company materials such as market maps, financial profiles, and competitive landscapes from structured data. The platform serves management consulting firms and investment professionals who need to produce analyst-ready documents and decks at scale.

Companies working in the same space as Objective Biotechnology.

Frequently asked questions

What does Objective Biotechnology do?: Objective Biotechnology develops neurotechnology tools for cortex-wide optical access and neural recordings in unrestrained rodent models, along with automated microinjection systems for large-scale genetic manipulation and embryo microinjection. Its products serve researchers working with biological systems.
How much funding has Objective Biotechnology raised?: Objective Biotechnology has disclosed $715K raised across 1 round.
Where is Objective Biotechnology headquartered?: Objective Biotechnology is headquartered in Minneapolis, US.